These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 361891)

  • 21. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 23. Soluble factor(s) from LPS-activated macrophages induce cytotoxic T cell differentiation from alloantigen-primed spleen cells.
    Klimpel GR
    J Immunol; 1980 Sep; 125(3):1243-9. PubMed ID: 6967896
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.
    Adams DO; Marino PA
    J Immunol; 1981 Mar; 126(3):981-7. PubMed ID: 7007505
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoregulatory functions of BCG-elicited alveolar macrophages in cell-mediated immune responses.
    Igietseme JU; Herscowitz HB
    Reg Immunol; 1988; 1(3):172-81. PubMed ID: 3079425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
    Glaser M; Bonnard GD; Herberman RB
    J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of non-specific cytotoxic cells in Listeria-susceptible and -resistant mouse strains.
    Wood P; Cheers C
    Immunology; 1985 Jan; 54(1):113-9. PubMed ID: 3918933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
    Gros P; Skamene E; Forget A
    J Immunol; 1983 Oct; 131(4):1966-72. PubMed ID: 6311901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG.
    Koren HS; Meltzer MS; Adams DO
    J Immunol; 1981 Mar; 126(3):1013-5. PubMed ID: 7007498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of a delayed type hypersensitivity reaction on the cytotoxic activity of macrophages, natural and antibody-dependent killer cells].
    Gordienko SM
    Eksp Onkol; 1987; 9(1):30-4. PubMed ID: 3816657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium chelonae sensitisation induces CD4(+)-mediated cytotoxicity against BCG.
    Ho P; Zhang L; Wei X; Seah GT
    Eur J Immunol; 2009 Jul; 39(7):1841-9. PubMed ID: 19585510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Demonstration of the antitumour effect of in vivo macrophage activation.
    Parr I
    Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4607926
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro induction of cell-mediated immunity to murine leukemia cells. VII. Methods for augmenting the induction and expression of cytotoxic response in vitro to syngeneic tumors.
    Kedar E; Lupu T; Schwartzbach M; Avraham Y
    J Immunol Methods; 1979; 26(2):157-71. PubMed ID: 155712
    [No Abstract]   [Full Text] [Related]  

  • 40. Effector cells for antibody-dependent cell mediated cytotoxicity. I. Increased cytotoxicity after priming with BCG-SS.
    Pollack SB
    Cell Immunol; 1977 Mar; 29(2):373-81. PubMed ID: 324637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.